nad has been researched along with cardiovascular agents in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeva, LI; Ershov, VI; Kazantseva, ST; Khavinson, VKh; Pavlenko, VS | 1 |
| Conseiller, C; Degeorges, M; Duboc, D; Py, A; Renault, G; Toussaint, M | 1 |
| Colantuono, G; Di Venosa, N; Fiore, T; Moro, N; Paradies, G; Petrosillo, G; Ruggiero, FM; Tiravanti, E | 1 |
| Mericskay, M | 1 |
| Brenner, C; London, B; Matasic, DS | 1 |
2 review(s) available for nad and cardiovascular agents
| Article | Year |
|---|---|
Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: Pathophysiological implications and therapeutic potential.
Topics: Animals; Calcium Signaling; Cardiovascular Agents; Energy Metabolism; Epigenesis, Genetic; Heart Failure; Homeostasis; Humans; Mitochondria, Heart; Myocardium; NAD; Poly(ADP-ribose) Polymerases; Signal Transduction; Sirtuins | 2016 |
Emerging potential benefits of modulating NAD
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Dietary Supplements; Energy Metabolism; Humans; Myocytes, Cardiac; NAD; Oxidation-Reduction; Signal Transduction | 2018 |
3 other study(ies) available for nad and cardiovascular agents
| Article | Year |
|---|---|
[Effects of a polypeptide drug on the state of energy metabolism of myocardial cells in hypoxic and ischemic conditions].
Topics: Animals; Cardiovascular Agents; Coronary Disease; Heart; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Myocardial Infarction; Myocardium; NAD; Oxygen Consumption; Peptides; Rats; Succinates | 1991 |
[The use of laser fluorometry of NADH in cardiology].
Topics: Cardiovascular Agents; Fluorometry; Heart Arrest, Induced; Humans; Lasers; Myocardial Revascularization; Myocardium; NAD | 1987 |
Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Topics: Animals; Antioxidants; Calcium; Cardiolipins; Cardiovascular Agents; Cyclosporine; Cytochromes c; Heart Rate; In Vitro Techniques; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Melatonin; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NAD; Necrosis; Perfusion; Rats; Rats, Wistar; Recovery of Function; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2009 |